Home  About LNU  News  Departments  Schools & Specialties  Faculty  Global  Alumni 
College of Liberal Arts
School of History
College of Philosophy and Public Administration
School of Economics
College of Law
Business School
College of Foreign Studies
School of Marxism
Asia-Australia Business College
Sunwah International Business School
School of Art
School of International Studies
School of Mathematics
School of Physics
College of Chemistry
School of Life Science
School of Environmental Sciences
School of Information
College of Light Industry
School of Pharmaceutical Science
Institute of Population Research
College of Communication
School of Journalism and Communication
School of Innovation and Entrepreneurship
Address:No. 66 Chongshan Middle Road, Huanggu District, Shenyang, Liaoning Prov., China
School of Pharmaceutical Science
Position: Home>>Faculty>>School of Pharmaceutical Science >>Content


LV Jing     MENG Xuelian     LIU Mingxia     LIU Hongsheng    
LIANG Xiao     HAO Aijun     DING Shi     WANG Yang    
WANG Xin     WANG Xiaofang     SANG Yuli     LIU Yufeng    
LIU Yu     LIU Ju     LIU Bingmi     LIU Bin    
LI Li     CHEN Lijiang     YE Chen     CHEN Changlan    

MENG Xuelian
2020-07-06 16:06  

Prof. MENG Xuelian obtains her B.Sc and master’s degree in Liaoning University in China, with emphasis on environmental science. Subsequently, she completes her Ph.D in pharmacology in Shenyang Pharmaceutical University in China. She has joined the School of Pharmaceutical Science, Liaoning University from 2008. The focus of her research is on the drug screening and mechanism of neurodegenerative diseases. To date, more than 50 scientific papers are published in peer-reviewed pharmaceutical journals.

 Academic backgroud:

B.Sc Liaoning University 2002

Master Liaoning University 2005

Ph.D Shenyang Pharmaceutical University 2008

 Career highlights:

Professor, School of Pharmaceutical Science, Liaoning University (2008– )

 Research highlights:

1.  Drug screening and mechanism of neurodegenerative diseases

2.  Pharmacology of anti-inflammatory and anticancer agents.


1.  Mechanism of bisbenzylisoquinoline alkaloids on hyperactivation of microglia and macrophage. National Science Foundation for Young Scholars of China.

2.  Molecular mechanism of nine bisbenzylisoquinoline alkaloids on microglial activation by ROS/NF-κB pathway.  Project of Science and Technology Department of Liaoning Province.

3. Protective effects of 12 bisbenzylisoquinoline alkaloids on -induced PC12 cells injury and their anti-Alzheimer's disease effects by Ca2 +-CaM/CaMKII signaling pathway. Project of Science and Technology Department of Liaoning Province.

4.Study on the structure-activity relationships of flavonoids inhibiting the activation of microglia. Project of Education Department of Liaoning Province.


[1] Meng XL, Chen ML, Chen CL, Gao CC, Li C, Wang D, Liu HS, Xu CB. Bisbenzylisoquinoline alkaloids of lotus (Nelumbo nucifera Gaertn.) seed embryo inhibit lipopolysaccharide-induced macrophage activation via suppression of Ca2+-CaM/CaMKII pathway. Food and Agricultural Immunology. 2019, 30(1): 878–896.

[2] Meng XL, Chen CL, Liu YY, Su SJ, Gou JM, Huan FN, Wang D, Liu HS, Ben SB, Lu J. Selenoprotein SELENOK Enhances the Migration and Phagocytosis of Microglial Cells by Increasing the Cytosolic Free Ca2+ Level Resulted from the Up-Regulation of IP3R. Neuroscience. 2019, 406: 38-49.

 [3] Chen ML, Gou JM, Meng XL*, Chen CL, Liu XN. Cepharanthine, a bisbenzylisoquinoline alkaloid, inhibits lipopolysaccharide-induced microglial activation. Pharmazie. 2019, 74: 606-610.

[4] Meng XL, Zheng LC, Liu J, Gao CC, Qiu MC, Liu YY, Lu J, Wang D, Chen CL. Inhibitory effects of three bisbenzylisoquinoline alkaloids on lipopolysaccharide-induced microglial activation. RSC Advances. 2017, 7: 18347-18357.

[5] Meng XL, Zhang HL, Feng LL, Chen ML, Liu YY, Yu X, Huan FN, Lu J, Wang D, Liu HS, Chen CL. Selenoprotein SelK increases the secretion of insulin from MIN6 β cells. RSC Advances, 2017, 7: 35038-35047.

[6] Ma XP, Li XZ, Li WL, Wang D, Xu CB, Meng XL*. Identification and characterization of a cold-adapted and halotolerant nitrobenzene-degrading bacterium. RSC Advances. 2015, 5: 80276-80282.

[7] Xu CB, Gu JL, Ma XP, Dong T, Meng XL*. Investigation on the interaction of pyrene with bovine serum albumin using spectroscopic methods. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2014,125:391-395.

[8] Meng XL, Yang JY, Chen GL, Wang LH, Zhang LJ, Wang S, Li J, Wu CF. Effects of resveratrol and its derivatives on lipopolysaccharide-induced microglial activation and their structure-activity relationships. Chemico-Biological Interactions. 2008, 174: 51-59.

[9] Meng XL, Yang JY, Chen GL, Zhang LJ, Wang LH, Li J, Wang JM, Wu CF. RV09, a novel resveratrol analogue, inhibit NO and TNF-α production by LPS-activated microglia. International Immunopharmacology. 2008, 8: 1074-1082.

[10] Meng XL, Chen GL, Yang JY, Wang S, Wu CF, Wang JM. Inhibitory effect of a novel resveratrol derivative on nitric oxide production in lipopolysaccharide-activated microglia. Pharmazie, 2008, 63: 671-675.


School of Pharmaceutical Science, Liaoning University,

No.66 Chongshan Middle Road, Huanggu District, Shenyang 110036, Liaoning, China

Tel: 024-62202469

Fax: 024-62202469

Email: rubymxl@163.com

Previous: LV Jing
Next: LIU Mingxia
Close Window


Copyright © 2016 Liaoning University All Rights Reserved Shenyang China